U-47700 is a synthetic opioid of the benzamide chemical class that produces analgesic, sedating, and euphoric effects. Developed by Upjohn in the 1970s through extensive structure-activity research, it demonstrates approximately 7.5 times the potency of morphine. Despite its research origins, U-47700 has very little history of human use and limited toxicity data. Reports indicate unusual caustic properties that may cause significant tissue damage, particularly when injected.
Also known as: U4, Pink, Pinky, Pink heroin
Classification
Chemical: Opioid
Psychoactive: Depressant
Tag: Benzamide
Tag: Habit-Forming
Tag: Research-Chemical
Tag: Synthetic opioid
Effects
Analgesia
Pupil Constriction
Respiratory Depression
Increased Heart Rate
Sedation
Muscle Relaxation
Euphoria
Mood Lift
Anxiety
Anxiety Suppression
Cognitive Euphoria
Cognitive Fatigue
Dulled Perception
Appetite Suppression
Sexual Dysfunction
Light Sensitivity
Disinhibition
Tactile Suppression
Routes of Administration
Oral
Dosage
Heavy: 25 mg
Light: 5 – 7.5 mg
Common: 7.5 – 15 mg
Strong: 15 – 25 mg
Threshold: 5 mg
Duration
Onset: 0.25 h
After Effects: 1-4 h
Insufflated
Dosage
Heavy: 10 mg
Light: 2 – 6 mg
Common: 6 – 8 mg
Strong: 8 – 10 mg
Threshold: 2 mg
Duration
Onset: 0.1-0.2 h
Comeup: 0.25-0.33 h
Peak: 1-2 h
After Effects: 2-4 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
U-47700 - מדריך חומרים של DrugsPRO
U-47700: U-47700 is a synthetic opioid of the benzamide chemical class that produces analgesic, sedating, and euphoric effects. Developed by Upjohn in the 1970s through extensive structure-activity research, it demonstrates approximately 7.5 times the potency of morphine. Despite its research origin